Deal Library / Pharma BD Deal Intelligence

Watson Pharmaceuticals, Inc. — Pharma Deals

The Pharma Closeout tracks 4 deals, $8.2B in disclosed deal value, 4 with a post-close Outcome Score for Watson Pharmaceuticals, Inc..

Median Critic Score: 84  ·  Median Outcome Score: 74

Best outcome: Watson Pharmaceuticals, Inc. / Actavis Group (97)  ·  Weakest outcome: Watson Pharmaceuticals, Inc. / Specifar Pharmaceuticals S.A. (44)

All 4 deals

• Watson Pharmaceuticals, Inc. / Actavis Group — 2012 · $5.9B · Worked — the deal delivered on its rationale.
• Watson Pharmaceuticals, Inc. / Arrow Group — 2009 · $1.8B · Worked — the deal delivered on its rationale.
• Watson Pharmaceuticals, Inc. / Eden Biodesign Limited — 2010 · $15M · Largely worked — most objectives met.
• Watson Pharmaceuticals, Inc. / Specifar Pharmaceuticals S.A. — 2011 · $562M · Underwhelmed — fell short of the thesis.

← Deal Library  ·  Interactive search  ·  How we score deals